Efficacy and Safety of Elective Switching from Intravenous to Subcutaneous Infliximab [CT-P13]: A Multicentre Cohort Study.
Smith PJ, Critchley L, Storey D, Gregg B, Stenson J, Kneebone A, Rimmer T, Burke S, Hussain S, Yi Teoh W, Vazeille S, Serna S, Steel A, Derbyshire E, Collins P, Dibb M, Flanagan P, Probert C, Verma AM, Subramanian S.
Smith PJ, et al.
J Crohns Colitis. 2022 Sep 8;16(9):1436-1446. doi: 10.1093/ecco-jcc/jjac053.
J Crohns Colitis. 2022.
PMID: 35390141
Free PMC article.